- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 16/42 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against immunoglobulins (anti-idiotypic antibodies)
Patent holdings for IPC class C07K 16/42
Total number of patents in this class: 1166
10-year publication summary
|
71
|
80
|
76
|
76
|
92
|
94
|
95
|
100
|
82
|
75
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10707 |
36 |
| Genentech, Inc. | 4012 |
35 |
| Chugai Seiyaku Kabushiki Kaisha | 1371 |
31 |
| Hoffmann-La Roche Inc. | 3489 |
25 |
| F. Hoffmann-La Roche AG | 7946 |
23 |
| Janssen Biotech, Inc. | 1564 |
22 |
| H. Lundbeck A/S | 1250 |
22 |
| Xencor, Inc. | 394 |
21 |
| Sanofi | 4101 |
20 |
| Genmab A/S | 431 |
16 |
| Amgen Inc. | 4122 |
15 |
| The Regents of the University of California | 20153 |
13 |
| Institut Pasteur | 787 |
13 |
| Ablynx N.V. | 400 |
12 |
| Quiapeg Pharmaceuticals AB | 45 |
12 |
| Regeneron Pharmaceuticals, Inc. | 4370 |
12 |
| Dana-Farber Cancer Institute, Inc. | 2602 |
10 |
| Acquiom Agency Services LLC, AS Collateral Agent | 30 |
9 |
| Centre National de La Recherche Scientifique | 10595 |
8 |
| The Johns Hopkins University | 5730 |
8 |
| Other owners | 803 |